NFKB1 and ovarian cancer: demonstrated that small molecule epigenetic inhibitors modulate key cellular signaling pathways, including NF-κB, TGFβ and WNT signaling, as well as major metabolic pathways, such as fatty acid metabolism and the TCA cycle, ultimately reducing platinum resistance in ovarian cancer cell lines (54).